|
|
| About site: Biotechnology and Pharmaceuticals/Pharmaceuticals/Research and Development - Centocor Inc. |
Return to Business
|
| About site: http://www.centocor.com/ |
Title: Biotechnology and Pharmaceuticals/Pharmaceuticals/Research and Development - Centocor Inc. Pharmaceutical company makes Remicade, new treatment for Crohn's Disease.
|
|
|
|
|
Centre_for_Photobiology_and_Photodynamic_Therapy The Leeds centre brings together more than 40 experts in biochemistry, chemistry, physics, biomedical science and clinical medicine to develop the new technology known as 'Photodynamics'. [more]
| Chembiotek_Research_International Chembiotek, a research company set up at Salt Lake, Kolkata offers state-of-the-art, creative technology to pharmaceutical, chemical and biotechnology industries. [more]
| ChemGenex_Therapeutics,_Inc_ Drug research company, developing targeted medicines for the treatment of cancer, diabetes, obesity and depression based in Australia. [more]
| ChemOvation_Ltd A leading provider of integrated drug discovery services to the Pharmaceutical and Biotechnology sectors. [more]
| Chipscreen_Biosciences_Ltd_ Contract drug discovery and development company, in Shenzhen, China. [more]
| ChiRhoClin,_Inc Studies, publications, and news about the diagnostic drugs, synthetic human and porcine secretin. [more]
|
|
| Alexa statistic for http://www.centocor.com/ |
|
| Related sites for http://www.centocor.com/ |
| Chlorion_Pharma Quebec-based pharmaceutical company. Research on chronic and neuropathic pain based on chloride ion imbalance in the spinal cord involving Kcc2. | | Chronogen_Inc A privately held drug discovery company developing drugs to treat age-dependent diseases, with an initial focus on cancer and cardiovascular disorders. | | Clincial_Horizons_Research,_Inc_ A leading clinical research company, located in Leonia, New Jersey, U.S.A. We specialize in providing high quality and expedient early phase drug development services. | | CNS_Healthcare_-_Clinical_Neuroscience_Solutions Advanced evaluations, treatments, monitoring, education, for those with psychiatric and neurological diseases. | | Cognitalis Drug design company focused on discovery and development of novel targeted medicines for the treatment of infectious diseases and cancer. | | Coley_Pharmaceutical_Group_(CPG) Developing innovative therapeutic and prophylactic products that harness the power of the immune system to treat cancer, allergy, asthma and infectious diseases, and help accelerate recovery of the im | | Collagenex_Pharmaceuticals Discovering, developing and commercializing new therapeutic agents. | | Collegium_Pharmaceutical Development of proprietary, late stage pharmaceutical products that add market value and clinical benefit to existing drugs. | | CSL_Ltd_ Develops, manufactures and markets vaccines and medications of biological origin. Includes career and investor information, and details of subsidiaries. Parkville, Victoria, Australia. | | Cyprotex A company focused on the prediction and experimental evaluation of ADME and Pharmacokinetics for drug discovery. | | Cytochroma,_Inc_ Development stage pharmaceutical company focused on the identification of cytochrome P450 enzymes for development of drug candidates and diagnostics. Located in Kingston, Ontario, Canada. | | Cytomyx Cytomyx provides its clients in the pharma-biotech and life-science communities with a complete range of genomic and proteomic discovery research services and reagents. | | Cytopia_Pty,_Ltd_ Privately-held Australian drug discovery company with a focus on inflammatory diseases such as: Asthma, Rheumatoid Arthritis, Allergic Rhinitis (Hay fever), Food allergy, Inflammatory Bowel Disease, i | | Debiopharm_S_A__&_Debioinnovation Drug development company takes both the financial risk and business venture of the entire drug development. | | The_Degge_Group,_Ltd_ Our mission is to optimize the therapy and prevention of disease in populations in the US and abroad through regulatory support, innovative epidemiological research, education, and product developmen | | Destiny_Pharma,_Ltd_ Pharmaceutical company specialised in photodynamic therapy (PDT). Destiny has a custom research service specialised in formulations, in phospholipids, liposomes and other solubilisation and suspension | | Diagnos-Techs,_Inc__-_Clinical_and_Research_Laboratory Originators of clinical saliva testing for female and male hormones. | | DOV_Pharmaceutical_Inc_ Biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, cardiovascular and urological disorders. | | Dr__J_R_K\'s_Siddha_Research_&_Pharmaceuticals_Pvt__Ltd_ Indian Pharmaceutical company manufacturing, marketing effective & safe herbal products for PSORIASIS, VITILIGO and any other skin aliments. | | Eisai_Pharmceuticals Guide to products and research for treatment of Alzheimers with Aricept. | | Elbion_AG_ Discovers and develops new small molecule drugs for treatment of inflammatory and central nervous system diseases. Includes company news, projects and profile of key management in Radebeul, Germany. | | Eli_Lilly_Pharmaceutical Eli Lilly Ireland, specialising in women's health, depression and schizophrenia. | | Elite_Pharmaceuticals A specialty pharmaceutical company principally engaged in the development of oral, controlled release products. | | Elkimia_Inc_ Canadian company providing products and services in the research and development of pharmaceuticals, including the sale of research quantities of specialty chemicals and brokering of scale-up and cust | | Ellipse-pharma A subsidiary of Bertin Group in the healthcare and life science division providing innovation and services in pharmaceutical development. | | Englebienne_&_Associates,_LLC Medical, pharmaceutical diagnostic projects using state-of-the-art pharmadiagnostic technologies. | | Equi-Tox,_Inc_ Veterinary pharmaceutical research and development firm dedicated to solutions for fescue toxicosis and other animal problems, especially for equine. | | EUCRO_European_Contract_Research_GmbH_&_Co_KG EUCRO - aims to supply companies with new product opportunities through own product development or co-development, globalisation of licences and trading of health care products. | | Eyetech_Pharmaceuticals,_Inc Biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. | | fOCUS_Pharmaceuticals A generic pharmaceutical research and development company. | | Friedrich_Schiller_Univ_,_Dept__of_Pharmaceutical_Technology Characterizing and developing conventional and novel drug delivery systems. Describes staff, research projects, courses offered, and publications. Located in Jena, Germany. | | Gaia_Research Research into Optimised Human Health through Natural Nutriture, with minimal use of dietary supplements and natural medicines, if at all. Eradication of AIDS, Parasites, Cancer, Cardiovascular Disease | | Genentech,_Inc_ Genentech's mission is to develop drugs to address significant unmet medical needs. Genentech manufactures and markets seven products that help save or improve lives every day. | | Gilead_Sciences,_Inc_ A biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for viral diseases, infectious diseases and cancer. It has research, development and manufacturing facil | | GloboMax_LLC Pharmaceutical CRO and PDO based in Hanover, MD with worldwide affiliate companies. | | Hauser_Laboratories A high quality research, development and testing laboratories offering a broad range of services to all phases of the pharmaceutical industry from early drug development through commercial manufacturi | | Health_Arising RxIBR is bringing innovations, Targeted Biologic Therapy from the Institute of Biologic Research into commercial fruition. | | Ichor_Medical_Systems,_Inc_ Developing platform electroporation technology for targeted in vivo delivery of membrane limited therapeutic agents including pharmaceutical compounds and DNA-based therapies. | | Institute_for_Diabetes_Discovery Research company and institute dedicated to the discovery of novel drugs and therapeutics for diabetes, its complications, obesity, and related disorders. | | Integrated_Biologics_Research_Laboratories The use of zwitterionic technology to treat disease. Research and development of new therapeutic modalities for cancer, immunology and infectious disease. |
|
This is businessgiftdepot.com cache of m/ as retrieved on 2009.01.07 businessgiftdepot.com's cache is the snapshot that we took of the page as we crawled the web. The page may have changed since that time.
|
Welcome to Centocor.com
//setTimeout("frames['introFrame'].location.href = 'intro.jsp'",2000)
var indexAccordion = [];
var indexexpander = [];
var jeff=0;
var whichSection='first';
var whichNest='';
var initSection='';
var nestedSec=null;
var found = false;
//';
var innerVarHTML=' we are the immunology pioneersCreative. Passionate. Visionary. Each of these words describes the biomedicines company that has already begun to unlock the secrets of the immune system – discoveries that have led to innovative treatments for conditions such as Crohn’s disease and rheumatoid arthritis.For more than 25 years, Centocor has been a leader in the field of biomedicines. Through the dynamic science of biotechnology, we continue to seek innovative ways to treat cancer and immune-mediated inflammatory disorders, such as rheumatoid arthritis and plaque psoriasis.moreVisit our new corporate blog CNTO411';
//var initSection='fourth';
//]]>
var SECTION_ONE = 0;
var SECTION_TWO = 6;
var SECTION_THREE = 14;
var SECTION_FOUR = 15;
var SECTION_FIVE = 21;
function accordioninit(){
// alert('accordioninit');
$$('span.toggler a').each(function(link, i){
// alert("i :"+i+" "+link.hash);
if (window.location.hash.test(link.hash)){
if(i < SECTION_TWO){
initSection='first';
whichNest='nested_one';
nestedSec=i;
}else if (i < SECTION_THREE){
initSection='second';
whichNest='nested_two';
nestedSec=i;
}else if(i == SECTION_THREE){
initSection='third';
frames['trailerFrame'].location.href = "/centocor/trailer.html";
nestedSec=i;
}else if(i < SECTION_FIVE){
whichNest='nested_four';
nestedSec=i-1;
initSection='fourth';
}else{
initSection='fifth';
nestedSec=i;
initSection='fifth';
}
found = true;
}
});
if (nestedSec==null) initSection='fourth';
//we define two arrays, containing our clients and project lists for the index page.
var indexheader = $S('.header');
var indexexpander = $S('.expander');
var indexsecondtierheader = $S('.secondtierheader');
var indexsecondtierexpander = $S('.secondtierexpander');
var indexthirdtierheader = $S('.thirdtierheader');
var indexthirdtierexpander = $S('.thirdtierexpander');
var inner_about = $S('.inner_about');
//then we create the accordion effect.
var open = 'all-closed';
var arrowToggler = $S('.arrowToggle');
$('showOne').addEvent('click', function() {
if(whichNest=="nested_one" && whichSection=='first'){
indexSecondTierAccordion.showThisHideOpen(SECTION_ONE);
whichNest=null;
}
});
$('showTwo').addEvent('click', function() {
if(whichNest=="nested_two" && whichSection=='second'){
indexSecondTierAccordion.showThisHideOpen(SECTION_TWO);
whichNest=null;
}
});
$('showFour').addEvent('click', function() {
if(whichNest=="nested_four" && whichSection=='fourth'){
indexSecondTierAccordion.showThisHideOpen(SECTION_FOUR-1);
whichNest=null;
}
});
$('showFive').addEvent('click', function() {
if(whichNest=="nested_five" && whichSection=='fifth'){
indexSecondTierAccordion.showThisHideOpen(SECTION_FIVE);
whichNest=null;
}
});
var indexAccordion = new Accordion(indexheader, indexexpander, {start: open, alwaysHide: false, opacity: true,
onActive: function(arrowToggler){
//arrowToggler.setProperty('id', 'arrowDown')
arrowToggler.className = "arrowDown";
},
onBackground: function(arrowToggler){
//arrowToggler.setProperty('id', 'arrowRight')
arrowToggler.className = "arrowRight";
},
onComplete: function(){
var el = this.elements[this.previous];
if (el != null && el.offsetHeight > 0) el.setStyle('height', 'auto');
if(whichSection=='first' || initSection=='first'){
if (!nestedSec){
indexSecondTierAccordion.showThisHideOpen(SECTION_ONE);
}else{
indexSecondTierAccordion.showThisHideOpen(nestedSec);
}
}
if(whichSection=='second' || initSection=='second'){
if (!nestedSec){
indexSecondTierAccordion.showThisHideOpen(SECTION_TWO);
}
}
if(whichSection=='third' || initSection=='third'){
//indexSecondTierAccordion.showThisHideOpen(null);
}
if(whichSection=='fourth' || initSection=='fourth'){
if (!nestedSec){
indexSecondTierAccordion.showThisHideOpen(SECTION_FOUR-1);
}
}
if(whichSection=='fifth' || initSection=='fifth'){
if (!nestedSec){
indexSecondTierAccordion.showThisHideOpen(SECTION_FIVE);
}
}
nestedSec=null;
}
});
var indexSecondTierAccordion = new Accordion(indexsecondtierheader, indexsecondtierexpander, {start: open, alwaysHide: false, opacity: true,
onActive: function(arrowToggler){
//arrowToggler.setProperty('id', 'arrowDown')
arrowToggler.className = "arrowDownNested";
},
onBackground: function(arrowToggler){
//arrowToggler.setProperty('id', 'arrowRight')
arrowToggler.className = "arrowRightNested";
},
onComplete: function(){
//alert('onComplete: function()');
var el = this.elements[this.previous];
if (el != null && el.offsetHeight > 0) el.setStyle('height', 'auto');
if(whichSection=='first' || initSection=='first'){
indexThirdTierAccordion.showThisHideOpen(0);
}
if(whichSection=='second' || initSection=='second'){
indexThirdTierAccordion.showThisHideOpen(4);
}
if(whichSection=='third' || initSection=='third'){
indexThirdTierAccordion.showThisHideOpen(3);
}
if(initSection=='fourth'){
var x=document.getElementById('inner_about').innerHTML;
// alert("x :"+x);
document.getElementById('inner_about').innerHTML=innerVarFlash;
}
if(whichSection=='fifth' || initSection=='fifth'){
indexThirdTierAccordion.showThisHideOpen(SECTION_FIVE);
}
}
});
var indexThirdTierAccordion = new Accordion(indexthirdtierheader, indexthirdtierexpander, { alwaysHide: false, opacity: true,
onActive: function(arrowToggler){
//arrowToggler.setProperty('id', 'arrowDown')
arrowToggler.className = "arrowDownNested";
},
onBackground: function(arrowToggler){
//arrowToggler.setProperty('id', 'arrowRight')
arrowToggler.className = "arrowRightNested";
},
onComplete: function(){
var el = this.elements[this.previousClick];
// if (el.offsetHeight > 0) el.setStyle('height', 'auto');
}
});
if(initSection=='first'){
//alert("hit_first");
indexAccordion.showThisHideOpen(0);
}
if(initSection=='second'){
//alert("hit_second");
indexAccordion.showThisHideOpen(1);
}
if(initSection=='third'){
//alert("hit_third");
indexAccordion.showThisHideOpen(2);
}
if(initSection=='fourth'){
//alert("hit_fourth");
indexAccordion.showThisHideOpen(3);
}
if(initSection=='fifth'){
//alert("hit_fifth");
indexAccordion.showThisHideOpen(4);
}
var newTips = new Tips($$('.toolTipImg'), {
maxTitleChars: 30,
onShow: function(tip){
tip.effects({duration: 500, transition: Fx.Transitions.quadInOut}).custom({'opacity': [0, 0.9]});
},
onHide: function(tip){
tip.effects({duration: 400, transition: Fx.Transitions.quadInOut}).custom({'opacity': [0.9, 0]});
}
});
}
function expand(jeff){
//alert("jeff is "+jeff);
if(jeff=='first'){
document.getElementById('inner_about').innerHTML=innerVarHTML;
frames['trailerFrame'].location.href = "/centocor/null.html";
}else if(jeff=='second'){
document.getElementById('inner_about').innerHTML=innerVarHTML;
frames['trailerFrame'].location.href = "/centocor/null.html";
}else if(jeff=='third'){
document.getElementById('inner_about').innerHTML=innerVarHTML;
frames['trailerFrame'].location.href = "/centocor/trailer.html";
}else if(jeff=='fourth'){
document.getElementById('inner_about').innerHTML=innerVarHTML;
frames['trailerFrame'].location.href = "/centocor/null.html";
}else if(jeff=='fifth'){
document.getElementById('inner_about').innerHTML=innerVarHTML;
frames['trailerFrame'].location.href = "/centocor/null.html";
}
whichSection=jeff;
initSection=null;
//whichNest='';
}
function nestexpand(vari){
whichNest=vari;
}
Window.onDomReady(function(){
accordioninit();
//checkHash();
});
function showResponse(request){
// alert(request);
};
function openFromFlash(){
MOOdalBox.open('/centocor/i/about/about-centocor.html','','');
}
Careers
Investor Relations
Site Map
Contact Us
each new day holds new potential
The potential to profoundly change the course of a disease.
That's not simply wishful thinking. It's the spirit the Immunology Pioneers at Centocor embrace every day in the course of their work.
That spirit has paid off with the development of a line of Centocor biomedicines that have revolutionized patient treatment in a number of disease categories, including ankylosing spondylitis, Crohn's disease, pediatric Crohn's disease, coronary angioplasty, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis.
more
immunology
Centocor is dedicated to finding new treatments to improve the lives of people living with immune-related conditions, specifically in the areas of:
Rheumatology
Gastroenterology
Dermatology
Pulmonology
biotechnology
Biologic medicines versus traditional pharmaceuticals: what’s the difference?
Biomedicines are typically derived from naturally occurring proteins, whereas traditional drugs are synthetic compounds. Biologic medicines are very specific in how they work on the underlying causes of disease, so developing them requires an understanding of the disease state and the mechanism of how the disease works.
more
how antibodies become biomedicine
How does Centocor create the drugs to treat disease? It starts with a process that allows our scientists to study the cells that create antibodies.
The human body makes antibodies that selectively target viruses and bacteria. Typically, the body makes antibodies to act on foreign substances. By understanding the specific benefits of a particular antibody, our Immunology Pioneers can develop monoclonal antibodies to act on specific substances that may be causing the disease.
more
current products
REMICADE® (infliximab)
Our greatest pioneering success to date is the development of REMICADE. REMICADE blocks the activity of a specific protein identified as an underlying cause of a number of autoimmune diseases. Click "more" to read the full indications and important safety information for REMICADE.
more
product pipeline
So what’s ahead for the Immunology Pioneers? We’re currently focusing on therapeutic areas of high unmet medical needs.
Our world-class product pipeline is robust with a variety of innovative products. Revolutionary products that are targeted at new therapeutic areas…and expanding current indications.
We’re exploring an array of new molecular entities that promise to take us well beyond our existing reach.
more
we are the immunology pioneers
Our scientists work diligently to unlock the secrets of the immune system. And one of the secrets they have uncovered is the interconnectedness of immune-related diseases.
The underlying cause of one disease could be a common element among many seemingly unrelated diseases. Therefore, by developing a biomedicine to treat the underlying cause, one drug could theoretically treat multiple diseases.
more
immunology
Centocor is dedicated to finding new treatments to improve the lives of people living with immune-related conditions, specifically in the areas of:
Rheumatology
Gastroenterology
Dermatology
Pulmonology
the science of biotechnology
What is the key to unlocking the secrets?
The Immunology Pioneers at Centocor have discovered the key can be found in the science of biotechnology.
Biotechnology is:
A collection of technologies that capitalize on the attributes of cells, such as their manufacturing capabilities, and put biological molecules, such as DNA and proteins, to work for us; it also refers to the type of manufacturing process of the drug (biological process vs. chemical process).
more
hybridomas/monoclonal antibodies
How does Centocor create the drugs to treat disease? It starts with the hybridoma.
The human body creates cells called B lymphocytes, or B cells, which in turn make antibodies that selectively target viruses and bacteria. The problem is B cells don’t live long, making them difficult to study. To resolve this, the scientists at Centocor fuse a B cell with a multiplier cell—which lives and thrives—to create a cell line of exact clones that lives indefinitely. These fused cells are called hybridomas, which continually produce antibodies, thus providing our scientists longer-living cells to work with in developing new therapies.
more
from biotechnology to biomedicine
Centocor not only helped pioneer the engineering of monoclonal antibodies in chronic disease therapy, we also set the standard for large-scale biomedicine manufacturing.
It involves an extremely complex process called perfusion bioreaction, which occurs in three phases and can take months to complete.
more
current products
REMICADE® (infliximab)
Our greatest pioneering success to date is the development of REMICADE. REMICADE blocks the activity of a specific protein identified as an underlying cause of a number of autoimmune diseases.
Click here for Full U.S. Prescribing Information and Medication Guide.
(Requires Adobe® Reader®. Click here to download.)
more
product pipeline
So what’s ahead for the Immunology Pioneers? We’re currently focusing on therapeutic areas of high unmet medical needs.
Our world-class product pipeline is robust with a variety of innovative products. Revolutionary products that are targeted at new therapeutic areas…and expanding current indications.
We’re exploring an array of new molecular entities that promise to take us well beyond our existing reach.
more
educational grants
What is DOME?
Centocor is committed to conducting business in a manner that achieves the highest level of patient care and healthcare professional education. The Department of Medical Education (DOME):
Communicates with customers about the appropriate use of Centocor products
Supports scientific and educational activities in Centocor's therapeutic areas of interest
Supports medical education that benefits Centocor's healthcare professionals and patients
What is STEP?
The grant application process is known as the Scientific, Therapeutic, and Educational Programming (STEP) Process.
more
press releases
 Subscribe Today!
12/19/2008
FDA ISSUES COMPLETE RESPONSE LETTER TO CENTOCOR FOR USTEKINUMAB BIOLOGIC LICENSE APPLICATION
11/13/2008
MEDVERSATION™ WEBSITE LAUNCHED BY CENTOCOR TO FACILITATE PHYSICIAN-PATIENT DIALOGUE ABOUT DRUG BENEFITS AND RISKS
more
people
There are people who follow formulas for answers. Then there are those who create the formulas.
The people of Centocor have a pioneering spirit that differentiates them. We have a natural curiosity about the world around us. We challenge conventional thinking. Push the boundaries of the possible. And have a real passion for our work.
more
Charitable Contributions and Community Relations
Welcome!
Philanthropy is important to Centocor.
We take seriously our responsibility to the communities in which we live and work. Centocor supports philanthropy throughout our global communities with donations and employee volunteerism. Our employee volunteers participate as teams and as individuals within their personal communities and in our corporate communities.
Our Credo states
We must be good citizens -- support good works and charities and bear our fair share of taxes. We must encourage civic improvements and better health and education. We must maintain in good order the property we are privileged to use, protecting the environment and natural resources.
more
locations
PA Locations
Corporate Headquarters/Horsham
800/850 Ridgeview Dr
Horsham, PA 19044
Chesterbrook
955/965 Chesterbrook Blvd
Wayne, PA 19087
more
resources
For your convenience, here are links to various websites concerning disease states that are relevant to our work at Centocor:
www.remicade.com
www.livingwithcrohnsdisease.com
www.livingwithuc.com
www.rastraighttalk.com
www.psoriaticdiseases.com
more
virtual press office
The Centocor Virtual Press Office (VPO) is designed to offer journalists immediate access to relevant company, product and disease-specific information. Resources available include recent press releases, product backgrounders, disease fact sheets, company history and leadership, as well as premium resources such as Science Writers' Guides, b-roll footage, high-resolution images and patients' stories.
Take me to the VPO
© Centocor, Inc. 1995 - 2007. Your use of the information on this site is subject to the terms of our
Legal Notice. Please see our
Privacy Policy,
Safe Harbor Privacy Policy, and
California Compliance Policy and Declaration. This site is published by Centocor, Inc., which is solely responsible for its contents. Capitalized product names are trademarks of Centocor. This information is intended for use by our customers, patients and healthcare professionals in the United States only. Centocor recognizes that the internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The prescribing information included here may not be appropriate for use outside the United States.
This page was last modified on: Dec 18 2008 at 14:53:59 EST
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src="http://www.centocor.com//" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
var pageTracker = _gat._getTracker("UA-1863405-1");
pageTracker._initData();
pageTracker._trackPageview();
|
|
| |
Pharmaceutical | company | makes | Remicade, | new | treatment | for | Crohn's | Disease. |
|
http://www.centocor.com/
Centocor Inc. 2009 January
dvd rental
dvd
Pharmaceutical company makes Remicade, new treatment for Crohn's Disease.
Rules
|
© 2005 Internet Explorer 5+ or Netscape 6+
|
|
Recommended Sites: 1.
Arts -
Business -
Computers -
Games -
Health -
Home -
Kids and Teens -
News -
Recreation -
Reference -
Regional -
Science -
Shopping -
Society -
Sports -
World
Miss Gallery
- Top Anime Hentai
- DVD rental by mail
- Personals - Mortgages - Loans - Hsbc - Refinance
|
